Frequently Asked Questions
How much does Relaxis cost?
Cost information and trial period details are available in the Relaxis Order Forms, which may be downloaded and viewed on the Start Your Trial page. Relaxis is a one-time investment in your RLS treatment and health. When compared with the annual co-pays many patients spend on doctor visits and RLS medications, the purchase price of Relaxis is comparable in the short-term and more affordable in the long-term considering the yearly cost of medication.
Will my insurance cover the cost?
No; however, if you have a Health Savings Account (HSA), you may charge the cost of Relaxis to your account.
How can I purchase Relaxis and get started on a trial period?
Please find instructions on the Start Your Trial page.
Can I use Relaxis while taking medications for RLS?
Yes. Approximately 40% of our clinical study participants were taking FDA-approved RLS medications during the trials. They had similar results as those not taking any RLS medications. The most commonly used RLS medications are Horizant (gabapentin), Mirapex (pramipexole), and Requip (ropinirole). Relaxis, which is a medical device, has no known drug interaction restrictions or any of the known RLS drug side effects.
What if Relaxis does not work for me?
Our clinical studies identified a small number of patients that are averse to vibration and cannot tolerate Relaxis. In total, we expect the Relaxis to help about 80% of primary RLS patients sleep better. We provide a 30-day trial period to all patients that purchase Relaxis. If you wish to return your device during or immediately following the trial period for any reason, you absolutely can. We provide a full refund less shipping and handling (where applicable). Cost information and trial details are available in the Relaxis Order Forms, which may be downloaded and viewed on the Start Your Trial page.
Is there evidence that Relaxis works?
Yes. Relaxis has been shown to improve the quality of sleep in patients with primary RLS through the use of vibratory counterstimulation. We completed two multi-center, double-blinded, randomized, controlled clinical studies covering 158 patients. These clinical studies resulted in four articles published as a series in a peer-reviewed medical journal. The study results and the complete article series can be downloaded and viewed on the Relaxis Clinical Data page or on the publisher’s website (Dove Press).
International Availability: Relaxis is currently available only in the United States.